SMALL INTERFERING RNA: REAL-LIFE DATA WITH A NEW FRONTIER IN HYPOLIPIDEMIC THERAPY
Anno:
2023
Inclisiran (Leqvio® 284 mg) is a new small interfering RNA that acts on the mRNA coding for the gene PCSK9. Inclisiran is indicated in adults with primary hypercholesterolemia (heterozygous familial and non-familial) or mixed dyslipidemia as an adjunct to diet alone or in combination with a statin or other…